Literature DB >> 21190829

Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture.

Carolin S Hoefig1, Kostja Renko, Josef Köhrle, Marc Birringer, Lutz Schomburg.   

Abstract

The essential micronutrient selenium (Se) exerts its biological effects mainly through enzymatically active selenoproteins. Their biosynthesis depends on the 21st proteinogenic amino acid selenocysteine and thus on dietary Se supply. Hepatically derived selenoprotein P (SEPP) is the central selenoprotein in blood controlling Se transport and distribution. Kidney-derived extracellular glutathione peroxidase is another relevant serum selenoprotein depending on SEPP for biosynthesis. Therefore, secretion of SEPP by hepatocytes is crucial to convert nutritional sources into serum Se, supporting Se status and selenoprotein biosynthesis in other tissues. In order to compare the bioactivity of 10 different selenocompounds, their dose-dependent toxicities and nutritional qualities to support SEPP and glutathione peroxidase biosynthesis were determined in a murine and two human liver cell lines. Characteristic dose- and time-dependent effects on viability and SEPP production were observed. Incubations with 100 nM sodium selenite, l- or dl-selenocystine, selenodiglutathione or selenomethyl-selenocysteine increased SEPP concentrations in the culture medium up to 6.5-fold over control after 72 h. In comparison, sodium selenate, l- or dl-selenomethionine or methylseleninic acid was less effective and increased SEPP by 2.5-fold under these conditions. As expected, ebselen did not increase selenoprotein production, supporting its classification as a stable selenocompound. Methylseleninic acid, l-selenocystine, selenodiglutathione or selenite induced cell death in micromolar concentrations, whereas selenomethionine or ebselen was not toxic within the concentration range tested. Our results indicate that hepatic selenoprotein production and toxicity of selenocompounds do not correlate with and rather represent compound-specific properties. The favourable profile of selenomethylselenocysteine warrants its consideration as a promising option for supplementation purposes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190829     DOI: 10.1016/j.jnutbio.2010.08.006

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  31 in total

1.  Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism.

Authors:  Ryuta Tobe; Min-Hyuk Yoo; Noelia Fradejas; Bradley A Carlson; Soledad Calvo; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Biochem J       Date:  2012-08-01       Impact factor: 3.857

2.  Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort.

Authors:  David J Hughes; Talita Duarte-Salles; Sandra Hybsier; Antonia Trichopoulou; Magdalena Stepien; Krasimira Aleksandrova; Kim Overvad; Anne Tjønneland; Anja Olsen; Aurélie Affret; Guy Fagherazzi; Marie-Christine Boutron-Ruault; Verena Katzke; Rudolf Kaaks; Heiner Boeing; Christina Bamia; Pagona Lagiou; Eleni Peppa; Domenico Palli; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Carlotta Sacerdote; Hendrik Bastiaan Bueno-de-Mesquita; Petra H Peeters; Dagrun Engeset; Elisabete Weiderpass; Cristina Lasheras; Antonio Agudo; Maria-José Sánchez; Carmen Navarro; Eva Ardanaz; Miren Dorronsoro; Oskar Hemmingsson; Nicholas J Wareham; Kay-Tee Khaw; Kathryn E Bradbury; Amanda J Cross; Marc Gunter; Elio Riboli; Isabelle Romieu; Lutz Schomburg; Mazda Jenab
Journal:  Am J Clin Nutr       Date:  2016-06-29       Impact factor: 7.045

3.  The integrative analysis of DNA methylation and mRNA expression profiles confirmed the role of selenocompound metabolism pathway in Kashin-Beck disease.

Authors:  Ping Li; Yujie Ning; Weizhuo Wang; Xiong Guo; Blandine Poulet; Xi Wang; Yan Wen; Jing Han; Jingcan Hao; Xiao Liang; Li Liu; Yanan Du; Bolun Cheng; Shiqiang Cheng; Lu Zhang; Mei Ma; Xin Qi; Chujun Liang; Cuiyan Wu; Sen Wang; Hongmou Zhao; Guanghui Zhao; Mary B Goldring; Feng Zhang; Peng Xu
Journal:  Cell Cycle       Date:  2020-08-20       Impact factor: 4.534

4.  Glutathione peroxidase mimic ebselen improves glucose-stimulated insulin secretion in murine islets.

Authors:  Xinhui Wang; Jun-Won Yun; Xin Gen Lei
Journal:  Antioxid Redox Signal       Date:  2013-08-09       Impact factor: 8.401

5.  Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.

Authors:  Rachel H L H Rueli; Daniel J Torres; Andrea S T Dewing; Arlene C Kiyohara; Stephanie M Barayuga; Miyoko T Bellinger; Jane H Uyehara-Lock; Lon R White; Paula I Moreira; Marla J Berry; George Perry; Frederick P Bellinger
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Selenium species-dependent toxicity, bioavailability and metabolic transformations in Caenorhabditis elegans.

Authors:  Isabelle Rohn; Talke Anu Marschall; Nina Kroepfl; Kenneth Bendix Jensen; Michael Aschner; Simon Tuck; Doris Kuehnelt; Tanja Schwerdtle; Julia Bornhorst
Journal:  Metallomics       Date:  2018-06-20       Impact factor: 4.526

7.  Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite.

Authors:  Marco Vinceti; Nikolay Solovyev; Jessica Mandrioli; Catherine M Crespi; Francesca Bonvicini; Elisa Arcolin; Eleni Georgoulopoulou; Bernhard Michalke
Journal:  Neurotoxicology       Date:  2013-05-31       Impact factor: 4.294

8.  Changes in selenoprotein P in substantia nigra and putamen in Parkinson's disease.

Authors:  Frederick P Bellinger; Arjun V Raman; Rachel H Rueli; Miyoko T Bellinger; Andrea S Dewing; Lucia A Seale; Marilou A Andres; Jane H Uyehara-Lock; Lon R White; G Webster Ross; Marla J Berry
Journal:  J Parkinsons Dis       Date:  2012       Impact factor: 5.568

9.  Seleno-β-lactoglobulin (Se-β-Lg) induces mitochondria-dependant apoptosis in HepG2 cells.

Authors:  Hai-Yu Ji; Juan Yu; An-Jun Liu
Journal:  Mol Biol Rep       Date:  2019-07-30       Impact factor: 2.316

10.  Therapeutic Potential of Selenium and Selenium Compounds in Cervical Cancer.

Authors:  Ewa Jablonska; Qi Li; Edyta Reszka; Edyta Wieczorek; Kateryna Tarhonska; Tong Wang
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.